ACTR-54. PHASE I TRIAL OF GENETICALLY MODIFIED HEMATOPOETIC PROGENITOR CELLS FACILITATING BONE MARROW CHEMOPROTECTION AND ENABLING TMZ/O6BG DOSE ESCALATION RESULTING IN IMPROVED SURVIVAL
Sloan, Andrew, Fung, Hua, Reese-Kroc, Jane, Rogers, Lisa, Murphy, Christopher, Lazrus, Hilard, Dropulic, Boro, Gerson, Stanton
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2016)
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2016)
Get full text
Journal Article